News from union therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 28, 2020, 03:50 ET UNION therapeutics appoints Dr. Kim Kjoeller as Chief Executive Officer and further strengthens leadership by appointing Dr. Günter Ditzinger as Chief Technology Officer

UNION therapeutics A/S ("UNION"), a privately held clinical stage pharmaceutical company focusing on infectious and inflammatory diseases, announced...


Oct 21, 2020, 02:19 ET Danish biotech UNION adds program to prevent COVID-19 with intranasal delivery of niclosamide

UNION therapeutics A/S (UNION) announces expansion of the clinical pipeline with the addition of UNI91103 (intranasal niclosamide) to prevent...


Aug 24, 2020, 23:38 ET UNION therapeutics A/S completes dosing of healthy volunteers with UNI911 (inhaled niclosamide) for COVID-19

UNION therapeutics A/S ("UNION"), a privately held, clinical stage pharmaceutical company, today announces the successful completion of dosing of 44...


Aug 13, 2020, 16:40 ET UNION therapeutics A/S enters option agreement to acquire worldwide exclusive license for COVID-19 technologies developed by TFF Pharmaceuticals, Inc.

Niclosamide identified as a potent inhibitor of SARS-Cov-2 by Institut Pasteur Korea, with potency >40x higher than remdesivir UNION has advanced...


Jul 21, 2020, 02:14 ET UNION therapeutics announces acquisition of PDE4i compound class from LEO Pharma with oral lead candidate (orismilast) in Phase 2

UNION therapeutics A/S ("UNION") today announced the completion of a transaction with LEO Pharma A/S (LEO Pharma) to acquire the global rights for...